- Home
- WSBF vs MOLN Comparison
WSBF vs MOLN Comparison
Compare WSBF & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBF
- MOLN
- Stock Information
- Founded
- WSBF 1921
- MOLN 2004
- Country
- WSBF United States
- MOLN Switzerland
- Employees
- WSBF N/A
- MOLN N/A
- Industry
- WSBF Savings Institutions
- MOLN
- Sector
- WSBF Finance
- MOLN
- Exchange
- WSBF Nasdaq
- MOLN Nasdaq
- Market Cap
- WSBF 299.6M
- MOLN 284.7M
- IPO Year
- WSBF N/A
- MOLN 2021
- Fundamental
- Price
- WSBF $14.96
- MOLN $4.98
- Analyst Decision
- WSBF
- MOLN Hold
- Analyst Count
- WSBF 0
- MOLN 1
- Target Price
- WSBF N/A
- MOLN $4.50
- AVG Volume (30 Days)
- WSBF 40.9K
- MOLN 8.5K
- Earning Date
- WSBF 10-22-2024
- MOLN 08-26-2024
- Dividend Yield
- WSBF 4.12%
- MOLN N/A
- EPS Growth
- WSBF 4.58
- MOLN N/A
- EPS
- WSBF 0.62
- MOLN N/A
- Revenue
- WSBF $132,560,000.00
- MOLN $8,749,165.00
- Revenue This Year
- WSBF N/A
- MOLN $8.70
- Revenue Next Year
- WSBF N/A
- MOLN N/A
- P/E Ratio
- WSBF $23.89
- MOLN N/A
- Revenue Growth
- WSBF N/A
- MOLN N/A
- 52 Week Low
- WSBF $9.62
- MOLN $3.32
- 52 Week High
- WSBF $16.36
- MOLN $12.70
- Technical
- Relative Strength Index (RSI)
- WSBF 56.85
- MOLN 48.33
- Support Level
- WSBF $13.52
- MOLN $4.70
- Resistance Level
- WSBF $14.62
- MOLN $4.97
- Average True Range (ATR)
- WSBF 0.34
- MOLN 0.34
- MACD
- WSBF 0.05
- MOLN 0.07
- Stochastic Oscillator
- WSBF 99.33
- MOLN 62.24
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.